IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
- PMID: 18039580
- DOI: 10.1016/j.cyto.2007.09.014
IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
Abstract
Interleukin-17A (IL-17A) contributes to the pathogenesis of arthritis. Data from experimental arthritis indicate IL-17 receptor signaling as a critical pathway in turning an acute synovitis into a chronic destructive arthritis. The identification of six IL-17 family members (IL-17A-F) may extend the role of this novel cytokine family in the pathogenesis of chronic destructive joint inflammation. Whether the successful anti-IL-17A cytokine therapy in murine arthritis can be effectively translated to human arthritis need to be tested in clinical trials in humans. Interestingly, IL-17A and IL-17F are secreted by the novel T helper subset named Th17. This novel pathogenic T cell population induces autoimmune inflammation in mice and is far more efficient at inducing Th1-mediated autoimmune inflammation in mice than classical Th1 cells (IFN-gamma). In addition to IL-17A and IL-17F, Th17 cells are characterized by expression of IL-6, TNF, GM-CSF, IL-21, IL-22 and IL-26. Th17 cells have been established as a separate lineage of T helper cells in mice distinct from conventional Th1 and Th2 cells. Whether this also applies to human Th17 and whether RA is a Th1 or a Th17 mediated disease is still not clear. This review summarizes the findings about the role of IL-17 in arthritis and discusses the impact of the discovery of the novel Th17 cells for arthritis. Further studies are needed to unravel the role of Th17 cells and the interplay of IL-17 and other Th17 cytokines in the pathogenesis of arthritis and whether regulating Th17 cell activity will have additional value compared to neutralizing IL-17A activity alone. This might help to reach the ultimate goal not only to treat RA patients but to prevent the development of this crippling disease.
Similar articles
-
RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.Gastroenterology. 2009 Jan;136(1):257-67. doi: 10.1053/j.gastro.2008.10.018. Epub 2008 Oct 9. Gastroenterology. 2009. PMID: 18992745
-
The IL-12/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis.Curr Opin Investig Drugs. 2009 May;10(5):452-62. Curr Opin Investig Drugs. 2009. PMID: 19431078 Review.
-
Properties and origin of human Th17 cells.Mol Immunol. 2009 Nov;47(1):3-7. doi: 10.1016/j.molimm.2008.12.019. Epub 2009 Feb 3. Mol Immunol. 2009. PMID: 19193443 Review.
-
Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.Arthritis Rheum. 2010 Apr;62(4):1043-50. doi: 10.1002/art.27336. Arthritis Rheum. 2010. PMID: 20131264
-
Th17 cytokines and their emerging roles in inflammation and autoimmunity.Immunol Rev. 2008 Dec;226:87-102. doi: 10.1111/j.1600-065X.2008.00712.x. Immunol Rev. 2008. PMID: 19161418 Review.
Cited by
-
Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.Indian J Med Res. 2012 Apr;135(4):513-9. Indian J Med Res. 2012. PMID: 22664499 Free PMC article.
-
The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss.Nat Immunol. 2012 Mar 25;13(5):465-73. doi: 10.1038/ni.2260. Nat Immunol. 2012. PMID: 22447028 Free PMC article.
-
Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.Periodontol 2000. 2010 Feb;52(1):141-62. doi: 10.1111/j.1600-0757.2009.00324.x. Periodontol 2000. 2010. PMID: 20017800 Free PMC article. Review.
-
Transcriptome Analysis of Monocytes and Fibroblasts Provides Insights Into the Molecular Features of Periodontal Ehlers-Danlos Syndrome.Front Genet. 2022 Apr 28;13:834928. doi: 10.3389/fgene.2022.834928. eCollection 2022. Front Genet. 2022. PMID: 35571048 Free PMC article.
-
Therapeutic Treatment of Arthritic Mice with 15-Deoxy Δ12,14-Prostaglandin J2 (15d-PGJ2) Ameliorates Disease through the Suppression of Th17 Cells and the Induction of CD4+CD25-FOXP3+ Cells.Mediators Inflamm. 2016;2016:9626427. doi: 10.1155/2016/9626427. Epub 2016 Oct 31. Mediators Inflamm. 2016. PMID: 27872515 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical